Back to Woodline Partners LP Woodline Partners LP

ALNYALNY
8 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in ALNYLAM PHARMACEUTICALS INC

Woodline Partners LP holds 246,282 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $74.1M as of 2026-Q2. The position was increased (+1.0% shares). ALNY represents 0.2% of Woodline Partners LP's portfolio.

Current Value

$74.1M

Current Shares

246,282

Total Value Change

+$51.5M

Total Shares Change

+151,214

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
246,282
+1.0%
$74.1M0.2%$301.03
36
2026-Q1
Increased
243,883
+138x
$80.7M0.3%$330.87
57
2025-Q4
Decreased
1,759
-98.1%
$699,4660.0%$397.65
0
2025-Q3
Decreased
91,791
-85.3%
$41.9M0.2%$456.00
0
2025-Q2
Increased
623,115
+298.3%
$203.2M1.1%$326.09
78
2025-Q1
New
156,464
-
$42.2M0.3%$270.02
48
2023-Q1
Exited
0
-100.0%
$00.0%$200.32
0
2022-Q4
New
95,068
-
$22.6M0.3%$237.65
47

Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used